Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging

NeuroImage

Volumn 21, Issue 1, 2004, Pages 229-235

  Eckert, Thomas ^a   Sailer, Michael ^a   Kaufmann, Joern ^a   Schrader, Christoph ^b   Peschel, Thomas ^b   Bodammer, Nils ^a   Heinze, Hans Jochen ^a   Schoenfeld, Mircea Ariel ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Magnetization transfer imaging; Multiple system atrophy; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CELL DENSITY; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLOBUS PALLIDUS; HUMAN; MALE; MYELINATION; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; WHITE MATTER;

EID: 1642451932     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2003.08.028     Document Type: Article

References (61)

1. Antonini A., Kazumata K., Feigin A.et al. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET. Mov. Disord. 13:1998;268-274.
2. Arnold G., Tatsch K., Kraft E., Oertel W.H., Schwarz J. Steele-Richardson-Olszewski-Syndrome: reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: 123IBZM SPECT and MRI study. Mov. Disord. 17:2002;557-562.
3. Berg D., Siefker C., Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J. Neurol. 248:2001;684-689.
4. Brooks D.J., Ibanez V., Sawle G.V.et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann. Neurol. 28:1990;547-555.
5. Brooks D.J., Ibanez V., Sawle G.V.et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann. Neurol. 31:1992;184-192.
6. Chabbert V., Ranjeva J.P., Sevely A., Boetto S., Berry I., Manelfe C. Diffusion- and magnetisation transfer-weighted MRI in childhood moya-moya. Neuroradiology. 40:1998;267-271.
7. Danielsen E.R., Ross B. Basic physics of MRS. Magnetic Resonance Spectrocopy Diagnosis of Neurological Diseases. 1998;5-22 Marcel Dekker AG, New York.
8. D'Antona R., Baron J.C., Samson Y.et al. Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain. 108:1985;785-799.
9. Davie C.A., Wenning G.K., Barker G.J.et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann. Neurol. 37:1995;204-210.
10. Diamond S.G., Markham C.H., Hoehn M.M., McDowell F.H., Muenter M.D. Multi-center study of Parkinson mortality with early versus later dopa treatment. Ann. Neurol. 22:1987;8-12.
11. Dousset V., Brochet B., Vital A.et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. Am. J. Neuroradiol. 16:1995;225-231.
12. Eidelberg D., Takikawa S., Moeller J.R.et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann. Neurol. 33:1993;518-527.
13. Eidelberg D., Moeller J.R., Ishikawa T.et al. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography. Neurology. 45:1995;1995-2004.
14. Fahn S., Elton R., Committee a.t.m.o.t.U.P.s.D.R.S.D. Unified Parkinson's disease rating scale. Fahn S., Marsden C.D., Calne D. Recent Developments in Parkinson's Disease. 1987;153-163 MacMillan, New York.
15. Federico F., Simone I.L., Lucivero V.et al. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry. 62:1997;239-242.
16. Federico F., Simone I.L., Lucivero V.et al. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical Parkinsonian disorders. Mov. Disord. 12:1997;903-909.
17. Filippi M., Rocca M.A., Martino G., Horsfield M.A., Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann. Neurol. 43:1998;809-814.
18. Gass A., Barker G.J., Kidd D.et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann. Neurol. 36:1994;62-67.
19. Ge Y., Grossman R.I., Babb J.S., Rabin M.L., Mannon L.J., Kolson D.L. Age-related total gray matter and white matter changes in normal adult brain. Part II: quantitative magnetization transfer ratio histogram analysis. Am. J. Neuroradiol. 23:2002;1334-1341.
20. Ghaemi M., Hilker R., Rudolf J., Sobesky J., Heiss W.D. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J. Neurol. Neurosurg. Psychiatry. 73:2002;517-523.
21. Gilman S., Low P.A., Quinn N.et al. Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci. 163:1999;94-98.
22. Golbe L.I., Davis P.H., Schoenberg B.S., Duvoisin R.C. Prevalence and natural history of progressive supranuclear palsy. Neurology. 38:1988;1031-1034.
23. Hanyu H., Asano T., Sakurai H., Takasaki M., Shindo H., Abe K. Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy. Neuroradiology. 43:2001;542-546.
24. Hauw J.J., Daniel S.E., Dickson D.et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 44:1994;2015-2019.
25. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology. 17:1967;427-442.
26. Hof P.R., Delacourte A., Bouras C. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol. 84:1992;45-51.
27. Hosaka K., Ishii K., Sakamoto S.et al. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. J. Neurol. Sci. 199:2002;67-71.
28. Hu M.T., White S.J., Herlihy A.H., Chaudhuri K.R., Hajnal J.V., Brooks D.J. A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. Neurology. 56:2001;1195-1200.
29. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry. 55:1992;181-184.
30. Hughes A.J., Daniel S.E., Blankson S., Lees A. A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neurol. 50:1993;140-148.
31. Hutchinson M., Raff U. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. Am. J. Neuroradiol. 21:2000;697-701.
32. Iannucci G., Dichgans M., Rovaris M.et al. Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 32:2001;643-648.
33. Kimura H., Meaney D.F., McGowan J.C.et al. Magnetization transfer imaging of diffuse axonal injury following experimental brain injury in the pig: characterization by magnetization transfer ratio with histopathologic correlation. J. Comput. Assist. Tomogr. 20:1996;540-546.
34. Krack P., Pollak P., Limousin P.et al. Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann. Neurol. 43:1998;180-192.
35. Lantos P.L. Neuropathological diagnostic criteria of multiple system atrophy: a review. Cruz-Sanchez F.F., Ravid R., Cuzner M.L. Neuropathological Diagnostic Criteria for Brain Banking. 1995;116-121 IOS Press, Amsterdam.
36. Lexa F.J., Grossman R.I., Rosenquist A.C. Dyke Award paper. MR of wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. Am. J. Neuroradiol. 15:1994;201-212.
37. Litvan I., Chase T.N. Traditional and experimental therapeutic approaches. Litvan I., Agid Y. Progressive Supranuclear Palsy: Clinical and Research Approaches. 1992;254-269 Oxford Univ. Press, New York.
38. Litvan I., Agid Y., Calne D.et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 47:1996;1-9.
39. Litvan I., Goetz C.G., Jankovic J.et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch. Neurol. 54:1997;937-944.
40. Litvan I., Booth V., Wenning G.K.et al. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J. Neural Transm. 105:1998;217-227.
41. McGowan J.C., Yang J.H., Plotkin R.C.et al. Magnetization transfer imaging in the detection of injury associated with mild head trauma. Am. J. Neuroradiol. 21:2000;875-880.
42. Naka H., Imon Y., Ohshita T.et al. Magnetization transfer measurements of brain structures in patients with multiple system atrophy. NeuroImage. 17:2002;1572-1578.
43. Ohshita T., Oka M., Imon Y., Yamaguchi S., Mimori Y., Nakamura S. Apparent diffusion coefficient measurements in progressive supranuclear palsy. Neuroradiology. 42:2000;643-647.
44. O'Neill J., Schuff N., Marks W.J. Jr., Feiwell R., Aminoff M.J., Weiner M.W. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov. Disord. 17:2002;917-927.
45. Plummer D. Dispimage: a display and analysis tool for medical images. Riv. Neuroradiol. 5:1992;488-495.
46. Pui M.H. Magnetization transfer analysis of brain tumor, infection, and infarction. J. Magn. Reson. Imaging. 12:2000;395-399.
47. Rademacher J., Engelbrecht V., Burgel U., Freund H., Zilles K. Measuring in vivo myelination of human white matter fiber tracts with magnetization transfer MR. NeuroImage. 9:1999;393-406.
48. Schocke M.F., Seppi K., Esterhammer R.et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology. 58:2002;575-580.
49. Schrag A., Good C.D., Miszkiel K.et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology. 54:2000;697-702.
50. Schulz J.B., Skalej M., Wedekind D.et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann. Neurol. 45:1999;65-74.
51. Seibyl J.P., Marek K.L., Quinlan D.et al. Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann. Neurol. 38:1995;589-598.
52. Seppi K., Schocke M.F., Esterhammer R.et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology. 60:2003;922-927.
53. Shoulson I. Experimental therapeutics of neurodegenerative disorders: unmet needs. Science. 282:1998;1072-1074.
54. Silver N.C., Barker G.J., MacManus D.G., Tofts P.S., Miller D.H. Magnetisation transfer ratio of normal brain white matter: a normative database spanning four decades of life. J. Neurol. Neurosurg. Psychiatry. 62:1997;223-228.
55. Taniwaki T., Nakagawa M., Yamada T.et al. Cerebral metabolic changes in early multiple system atrophy: a PET study. J. Neurol. Sci. 200:2002;79-84.
56. van der Flier W.M., van den Heuvel D.M., Weverling-Rijnsburger A.W.et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann. Neurol. 52:2002;62-67.
57. van Waesberghe J.H., Kamphorst W., De Groot C.J.et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol. 46:1999;747-754.
58. Wenning G.K., Odin P., Morrish P.et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42:1997;95-107.
59. Wenning G.K., Tison F., Ben-Shlomo Y., Daniel S.E., Quinn N. Multiple system atrophy: a review of 203 pathologically proven cases. Mov. Disord. 12:1997;133-147.
60. Wolff S.D., Balaban R.S. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn. Reson. Med. 10:1989;135-144.
61. Woods R.P., Mazziotta J.C., Cherry S.R. MRI-PET registration with automated algorithm. J. Comput. Assist. Tomogr. 17:1993;536-546.